Human type 3 5α-reductase is expressed in peripheral tissues at higher levels than types 1 and 2 and its activity is potently inhibited by finasteride and dutasteride.
about
The 5 alpha-reductase isozyme family: a review of basic biology and their role in human diseasesFinasteride concentrations and prostate cancer risk: results from the Prostate Cancer Prevention TrialAndrogen regulation of 5α-reductase isoenzymes in prostate cancer: implications for prostate cancer prevention.5α-reductase type 3 expression in human benign and malignant tissues: a comparative analysis during prostate cancer progression.Role of 5α-reductase inhibitors in benign prostatic diseases.NF-κB and androgen receptor variant 7 induce expression of SRD5A isoforms and confer 5ARI resistance.Androgen Receptor (AR) Gene (CAG)n and (GGN)n Length Polymorphisms and Symptoms in Young Males With Long-Lasting Adverse Effects After Finasteride Use Against Androgenic Alopecia.The role of intracrine androgen metabolism, androgen receptor and apoptosis in the survival and recurrence of prostate cancer during androgen deprivation therapy.Assessment of steroidogenic pathways that do not require testosterone as intermediate.Bioactive natural products for chemoprevention and treatment of castration-resistant prostate cancer.Conventional and novel stem cell based therapies for androgenic alopecia.Expression of steroidogenic enzymes and metabolism of steroids in COS-7 cells known as non-steroidogenic cells.Subcellular localization of the five members of the human steroid 5α-reductase family.Inhibition of dihydrotestosterone synthesis in prostate cancer by combined frontdoor and backdoor pathway blockade.Ten years of intraoperative floppy iris syndrome in the era of α-blockers.
P2860
Q21285041-FF06DB99-6D8D-4E3F-A541-06F8A67FE01DQ28547130-5B8D88B6-9354-444D-9664-6B59E02334B1Q34110419-6A36300F-D48B-411C-8A56-25F39BAC6F60Q34183936-CB4876AD-C15E-440B-A76D-E2DED758AE0CQ34254296-62105E20-C596-4107-AECE-1995954765C3Q37018606-2DF9C15D-FEE4-494A-99B7-333693F7A642Q37636067-9C065DBF-CE0D-49CB-84C7-AE3C0B96827EQ37709925-DB40CFC8-3D5E-476D-9750-29D6603F4366Q38471547-F7CE886D-5AAA-4E27-B732-B3B231FC3029Q38883820-BC03D85F-D5ED-49C8-B85B-B226288A6861Q42355136-50724F48-E582-4352-805C-89AF8199833FQ47825253-2E67A678-E49C-4FDA-9691-CF9F0AE5825DQ51792401-ED39F83F-CFF2-482B-A812-9A7F17D81C46Q52655045-B873A119-BB87-4C90-87C5-44C1755363D0Q55364267-2444EFD8-16C3-42C8-A4B8-F4FA2D93F5D9
P2860
Human type 3 5α-reductase is expressed in peripheral tissues at higher levels than types 1 and 2 and its activity is potently inhibited by finasteride and dutasteride.
description
2010 nî lūn-bûn
@nan
2010 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Human type 3 5α-reductase is e ...... y finasteride and dutasteride.
@ast
Human type 3 5α-reductase is e ...... y finasteride and dutasteride.
@en
Human type 3 5α-reductase is e ...... y finasteride and dutasteride.
@nl
type
label
Human type 3 5α-reductase is e ...... y finasteride and dutasteride.
@ast
Human type 3 5α-reductase is e ...... y finasteride and dutasteride.
@en
Human type 3 5α-reductase is e ...... y finasteride and dutasteride.
@nl
prefLabel
Human type 3 5α-reductase is e ...... y finasteride and dutasteride.
@ast
Human type 3 5α-reductase is e ...... y finasteride and dutasteride.
@en
Human type 3 5α-reductase is e ...... y finasteride and dutasteride.
@nl
P2093
P2860
P356
P1476
Human type 3 5α-reductase is e ...... y finasteride and dutasteride.
@en
P2093
Fernand Labrie
Kazutoshi Yamana
Van Luu-The
P2860
P304
P356
10.1515/HMBCI.2010.035
P577
2010-08-01T00:00:00Z